Why subclinical bacteriuria often shouldn't trigger antibiotics: full analysis
A new Worms & Germs Blog post from Scott Weese uses an unlikely source — Winnie the Pooh — to reinforce a message many antimicrobial stewardship advocates have been making for years: in cases of subclinical bacteriuria, doing nothing is often the right clinical choice. The core issue is straightforward. If bacteria are identified in urine from a properly collected sample, but the patient has no clinical signs of urinary tract disease, that finding alone usually doesn’t justify antimicrobial treatment. (sciencedirect.com)
That position didn’t emerge overnight. Veterinary UTI guidance has evolved over the past decade as clinicians and researchers have tried to separate true infection from colonization or incidental findings. The 2019 ISCAID guidelines, authored by Weese and colleagues, expanded recommendations across bacterial cystitis, pyelonephritis, prostatitis, catheter-associated infections, and subclinical bacteriuria, with antimicrobial stewardship as a central theme. (sciencedirect.com)
The key distinction is between clinical signs and lab findings. In dogs and cats, lower urinary tract signs such as hematuria, dysuria, pollakiuria, periuria, or stranguria support a diagnosis of bacterial cystitis when paired with appropriate testing. By contrast, subclinical bacteriuria refers to a positive urine culture in the absence of observed urinary tract disease. Clinician-facing reviews have stressed that animals with no clinical signs generally should not be cultured if the result would not change treatment, and they should not be routinely treated with antimicrobials if bacteriuria is found. Even recovery of a multidrug-resistant organism does not automatically mean treatment is warranted. (cliniciansbrief.com)
That recommendation can feel counterintuitive in practice, especially when a urinalysis flags bacteria or a culture comes back positive. But the supporting rationale is consistent across guidance and review articles: there is little evidence that subclinical bacteriuria, by itself, leads to worse outcomes in most dogs and cats, while unnecessary treatment may temporarily suppress bacteria only to be followed by recolonization, selection pressure, and increasing antimicrobial resistance. In other words, a positive culture can create pressure to act, even when the evidence argues for restraint. (cliniciansbrief.com)
Expert commentary in the veterinary literature has added an important nuance: subclinical bacteriuria may still matter diagnostically, even when it doesn’t merit antibiotics. David Senior, writing in Clinician’s Brief, describes it as a frequent finding that can serve as a sentinel for underlying disease or impaired host defenses. Reported associations include diabetes mellitus, hyperadrenocorticism, chronic kidney disease, urinary tract abnormalities, catheter use, incomplete bladder emptying, spinal cord injury, obesity, older age, and immunosuppression. For clinicians, that shifts the question from “What antibiotic should I use?” to “Why is this patient predisposed?” (cliniciansbrief.com)
Why it matters: For veterinary teams, this is a high-yield stewardship issue because urinary findings are a common trigger for antibiotic prescribing. The practical takeaway is to anchor treatment decisions to the patient, not the culture result alone. That means obtaining a careful history from the pet parent, confirming whether lower urinary tract signs are actually present, interpreting urinalysis in context, and resisting the urge to treat incidental bacteriuria. It also means using bacteriuria as a prompt to look for comorbidities or anatomic and functional risk factors that may need management, especially in older cats and medically complex patients. (sciencedirect.com)
The cat-specific literature supports that caution. Reviews in feline medicine note that subclinical bacteriuria is part of the broader UTI framework addressed by updated ISCAID guidance, and prevalence studies have linked bacteriuria in cats with factors such as age and concurrent disease rather than straightforward lower urinary tract infection. That’s especially relevant in feline practice, where lower urinary tract signs are common, but bacterial infection is not always the explanation. (journals.sagepub.com)
What to watch: The next phase is likely to be less about changing the headline recommendation and more about implementation — better antimicrobial stewardship workflows, clearer thresholds for when to culture, and more targeted workups for patients with recurrent or persistent bacteriuria but no clinical signs. Expect this topic to stay active as practices refine UTI protocols and as stewardship efforts continue to push against automatic treatment of abnormal lab results. (sciencedirect.com)